In PDAC, anti-CTLA-4 antibody can block the interaction between CTLA-4 and B7, block the inhibitory signal, and down-regulate the immune system, to induce the host’s inhibitory effect on tumor and produce a lasting anti-tumor effect (217, 218). Here, CTLA4 is linked to neoplasm.